Please assess the completion status of the following clinical trial:

Trial Title: Targeted Pharmacological and Behavioral Treatments for Smoking in Schizophrenia Study 1

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: BASIC_SCIENCE
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Men and women~2. Ages 18-65~3. Have schizophrenia or schizoaffective disorder~4. Would like to quit smoking within the next 6 months~5. Have smoked at least 10 cigarettes per day in the past year~6. Have breath CO level \> 10 ppm~7. Able to speak, read and comprehend English well enough to complete study procedures~Exclusion Criteria:~1. Pregnant, breast-feeding, or unwilling to use medically-approved contraception~2. Currently using varenicline, bupropion or nicotine replacement therapy for smoking cessation~3. Medical disease that would preclude participation~4. Unstable psychiatric conditions~5. Body mass index (BMI) \< 15 or \> 38 kg/m2~6. Past-month suicidal intention, with or without a specific plan~7. Positive urine drug screen or breath alcohol level \> 0.01% at screening

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- Varenicline (Type: ACTIVE_COMPARATOR): None
- Placebo (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).